HCC - HEPATOCELLULAR CARCINOMA
Clinical trials for HCC - HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HCC - HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for HCC - HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo shows promise for tough liver cancers
Disease control CompletedThis study looked at 244 people with advanced liver cancer that had spread into a major blood vessel. Researchers compared standard treatment (lenvatinib plus an immunotherapy drug) to the same treatment plus a direct liver chemo infusion. The goal was to see if the triple combin…
Matched conditions: HCC - HEPATOCELLULAR CARCINOMA
Sponsor: First Hospital of China Medical University • Aim: Disease control
Last updated May 17, 2026 06:49 UTC
-
Triple therapy shows promise in advanced liver cancer trial
Disease control CompletedThis study tested whether adding a third drug, ipilimumab, to a two-drug combination (atezolizumab and bevacizumab) helps people with advanced liver cancer live longer or have better tumor shrinkage. 229 participants received either the two-drug or three-drug treatment for up to …
Matched conditions: HCC - HEPATOCELLULAR CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: Federation Francophone de Cancerologie Digestive • Aim: Disease control
Last updated May 17, 2026 06:47 UTC
-
Liver cancer patients get a second chance with combo therapy
Disease control CompletedThis study looked at 24 adults with advanced liver cancer whose tumors continued to grow despite standard treatment with lenvatinib and a PD-1 inhibitor. Researchers added lenalidomide to see if it could help control the cancer again. The goal was to measure how long patients liv…
Matched conditions: HCC - HEPATOCELLULAR CARCINOMA
Phase: NA • Sponsor: Beijing Tsinghua Chang Gung Hospital • Aim: Disease control
Last updated May 17, 2026 06:47 UTC